For A Housing Recovery, Visit The Doctor: Buy DR Horton
- This article outlines the rationale for buying DR Horton stock today, and follows from my favourable macro view on US housing published in September.
- From its scale advantages to its consistent, conservative approach I discuss why DHI is the builder best poised to take advantage of improving broader conditions.
- Why now? DHI's formidable return to a first-time buyer market to coincide with new life in this key but mostly ignored segment.